Neoplasms Metastasis Completed Phase 3 Trials for Lenalidomide (DB00480)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00057616Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.Prevention